Company Hid Serious Problems with Aorta Graft Product Abdominal Aortic Aneurysm

Kahn Gauthier Swick is investigating possible Abdominal Aortic Aneurysms legal action against EndoVascular Technologies, Inc., a wholly-owned subsidiary of medical device manufacturer Guidant Corporation, on behalf of persons who were implanted with the Guidant EndoVascular's abdominal aortic aneurysm Ancure Endograft System, which is used to repair abdominal aortic aneurysm. EndoVascular has now admitted that Guidant lied to the government and concealed serious problems with the Abdominal Aortic Aneurysm device, leading to at least a dozen deaths. Guidant has also pled guilty to 10 felonies in a prosecution by the U.S. government.

Aortic Aneurysm Can Be A Killer

Approximately 40,000 patients undergo repair of abdominal aortic aneurysm in the United States each year. In spite of that, approximately 15,000 patients die from ruptured aneurysm, making abdominal aortic aneurysm rupture the 13th leading cause of death in the United States. This cause of premature death is entirely preventable providing that patients with abdominal aortic aneurysm can be diagnosed prior to rupture and undergo safe elective repair of the abdominal aortic aneurysm.

Historically, doctors dealt with abdominal aortic aneurysm through complex surgery. That entailed opening the abdominal cavity, moving aside the patient's internal organs, finding the aorta and locating the abdominal aortic aneurysm--a spot where the vessel is weakened and balloons out. Once abdominal aortic aneurysm is found, the surgeon would attach a graft to strengthen that point in the aorta.

The newer abdominal aortic aneurysm method advanced by EndoVascular avoided the dangers and complications of surgery. With it, a doctor inserted a catheter containing a polyester graft into an artery in the groin, then threaded it through the body until it reached the abdominal aortic aneurysm.

Our claim form will help you tell us about your abdominal aortic aneurysm lawsuit.